Literature DB >> 16220487

Random effects logistic models for analysing efficacy of a longitudinal randomized treatment with non-adherence.

Dylan S Small1, Thomas R Ten Have, Marshall M Joffe, Jing Cheng.   

Abstract

We present a random effects logistic approach for estimating the efficacy of treatment for compliers in a randomized trial with treatment non-adherence and longitudinal binary outcomes. We use our approach to analyse a primary care depression intervention trial. The use of a random effects model to estimate efficacy supplements intent-to-treat longitudinal analyses based on random effects logistic models that are commonly used in primary care depression research. Our estimation approach is an extension of Nagelkerke et al.'s instrumental variables approximation for cross-sectional binary outcomes. Our approach is easily implementable with standard random effects logistic regression software. We show through a simulation study that our approach provides reasonably accurate inferences for the setting of the depression trial under model assumptions. We also evaluate the sensitivity of our approach to model assumptions for the depression trial. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16220487     DOI: 10.1002/sim.2313

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  11 in total

1.  Semiparametric transformation models for causal inference in time to event studies with all-or-nothing compliance.

Authors:  Wen Yu; Kani Chen; Michael E Sobel; Zhiliang Ying
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2015-03-01       Impact factor: 4.488

Review 2.  Attrition and related trends in scientific rigor: a score card for ART adherence intervention research and recommendations for future directions.

Authors:  K Rivet Amico; Jennifer J Harman; Megan A O'Grady
Journal:  Curr HIV/AIDS Rep       Date:  2008-11       Impact factor: 5.071

3.  Adjustment for Variable Adherence Under Hierarchical Structure: Instrumental Variable Modeling Through Compound Residual Inclusion.

Authors:  Tyson H Holmes; Donna M Zulman; Clete A Kushida
Journal:  Med Care       Date:  2016-01-13       Impact factor: 2.983

4.  Joint mixed-effects models for causal inference with longitudinal data.

Authors:  Michelle Shardell; Luigi Ferrucci
Journal:  Stat Med       Date:  2017-12-04       Impact factor: 2.373

5.  Using an instrumental variable to test for unmeasured confounding.

Authors:  Zijian Guo; Jing Cheng; Scott A Lorch; Dylan S Small
Journal:  Stat Med       Date:  2014-06-15       Impact factor: 2.373

6.  Mediation analysis with principal stratification.

Authors:  Robert Gallop; Dylan S Small; Julia Y Lin; Michael R Elliott; Marshall Joffe; Thomas R Ten Have
Journal:  Stat Med       Date:  2009-03-30       Impact factor: 2.373

7.  Rationale and Design of the Randomized Evaluation of Default Access to Palliative Services (REDAPS) Trial.

Authors:  Katherine R Courtright; Vanessa Madden; Nicole B Gabler; Elizabeth Cooney; Dylan S Small; Andrea Troxel; David Casarett; Mary Ersek; J Brian Cassel; Lauren Hersch Nicholas; Gabriel Escobar; Sarah H Hill; Dan O'Brien; Mark Vogel; Scott D Halpern
Journal:  Ann Am Thorac Soc       Date:  2016-09

8.  A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention.

Authors:  David W Oslin; Kevin G Lynch; Helen M Pettinati; Kyle M Kampman; Peter Gariti; Lois Gelfand; Thomas Ten Have; Shoshana Wortman; William Dundon; Charles Dackis; Joseph R Volpicelli; Charles P O'Brien
Journal:  Alcohol Clin Exp Res       Date:  2008-07       Impact factor: 3.455

9.  Instrumental variable methods for causal inference.

Authors:  Michael Baiocchi; Jing Cheng; Dylan S Small
Journal:  Stat Med       Date:  2014-03-06       Impact factor: 2.373

10.  Nested Markov compliance class model in the presence of time-varying noncompliance.

Authors:  Julia Y Lin; Thomas R Ten Have; Michael R Elliott
Journal:  Biometrics       Date:  2009-06       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.